159 related articles for article (PubMed ID: 31283608)
1. Clinical Utility of 18F-Florbetaben PET for Detecting Amyloidosis Associated With Multiple Myeloma: A Prospective Case-Control Study.
Seo M; Cha HJ; Kim M; Park SH; Lim JH; Choi Y; Lee YJ; Park SH; Jo JC
Clin Nucl Med; 2019 Sep; 44(9):e503-e509. PubMed ID: 31283608
[TBL] [Abstract][Full Text] [Related]
2. Early Detection of Multiorgan Light-Chain Amyloidosis by Whole-Body
Ehman EC; El-Sady MS; Kijewski MF; Khor YM; Jacob S; Ruberg FL; Sanchorawala V; Landau H; Yee AJ; Bianchi G; Di Carli MF; Falk RH; Hyun H; Dorbala S
J Nucl Med; 2019 Sep; 60(9):1234-1239. PubMed ID: 30954943
[TBL] [Abstract][Full Text] [Related]
3. [18F]-Florbetaben PET/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and Mimicking Conditions.
Genovesi D; Vergaro G; Giorgetti A; Marzullo P; Scipioni M; Santarelli MF; Pucci A; Buda G; Volpi E; Emdin M
JACC Cardiovasc Imaging; 2021 Jan; 14(1):246-255. PubMed ID: 32771577
[TBL] [Abstract][Full Text] [Related]
4. Detection of cardiac amyloidosis with
Kircher M; Ihne S; Brumberg J; Morbach C; Knop S; Kortüm KM; Störk S; Buck AK; Reiter T; Bauer WR; Lapa C
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1407-1416. PubMed ID: 30798427
[TBL] [Abstract][Full Text] [Related]
5. 18F-Florbetaben: A New Tool for Amyloidosis Staging?
D'Estanque E; Chambert B; Moranne O; Kotzki PO; Boudousq V
Clin Nucl Med; 2017 Jan; 42(1):50-53. PubMed ID: 27801739
[TBL] [Abstract][Full Text] [Related]
6. PET-CT evaluation of amyloid systemic involvement with [
Genovesi D; Vergaro G; Emdin M; Giorgetti A; Marzullo P
J Nucl Cardiol; 2017 Dec; 24(6):2025-2029. PubMed ID: 28326465
[TBL] [Abstract][Full Text] [Related]
7. Extracardiac
Wagner T; Page J; Burniston M; Skillen A; Ross JC; Manwani R; McCool D; Hawkins PN; Wechalekar AD
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1129-1138. PubMed ID: 29651545
[TBL] [Abstract][Full Text] [Related]
8. Cardiac Amyloid Imaging with 18F-Florbetaben PET: A Pilot Study.
Law WP; Wang WY; Moore PT; Mollee PN; Ng AC
J Nucl Med; 2016 Nov; 57(11):1733-1739. PubMed ID: 27307344
[TBL] [Abstract][Full Text] [Related]
9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of in vivo
Bucerius J; Barthel H; Tiepolt S; Werner P; Sluimer JC; Wildberger JE; Patt M; Hesse S; Gertz HJ; Biessen EAL; Mottaghy FM; Sabri O
Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1119-1128. PubMed ID: 28321471
[TBL] [Abstract][Full Text] [Related]
11. PET quantification of 18F-florbetaben binding to β-amyloid deposits in human brains.
Becker GA; Ichise M; Barthel H; Luthardt J; Patt M; Seese A; Schultze-Mosgau M; Rohde B; Gertz HJ; Reininger C; Sabri O
J Nucl Med; 2013 May; 54(5):723-31. PubMed ID: 23471310
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of early-phase [
Daerr S; Brendel M; Zach C; Mille E; Schilling D; Zacherl MJ; Bürger K; Danek A; Pogarell O; Schildan A; Patt M; Barthel H; Sabri O; Bartenstein P; Rominger A
Neuroimage Clin; 2017; 14():77-86. PubMed ID: 28138429
[TBL] [Abstract][Full Text] [Related]
13. Quantitative [
Khor YM; Cuddy S; Harms HJ; Kijewski MF; Park MA; Robertson M; Hyun H; Di Carli MF; Bianchi G; Landau H; Yee A; Sanchorawala V; Ruberg FL; Liao R; Berk J; Falk RH; Dorbala S
Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1998-2009. PubMed ID: 31807884
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal assessment of cerebral β-amyloid deposition in mice overexpressing Swedish mutant β-amyloid precursor protein using 18F-florbetaben PET.
Rominger A; Brendel M; Burgold S; Keppler K; Baumann K; Xiong G; Mille E; Gildehaus FJ; Carlsen J; Schlichtiger J; Niedermoser S; Wängler B; Cumming P; Steiner H; Herms J; Haass C; Bartenstein P
J Nucl Med; 2013 Jul; 54(7):1127-34. PubMed ID: 23729696
[TBL] [Abstract][Full Text] [Related]
15. 18F-FDG PET/CT in primary AL hepatic amyloidosis associated with multiple myeloma.
Son YM; Choi JY; Bak CH; Cheon M; Kim YE; Lee KH; Kim BT
Korean J Radiol; 2011; 12(5):634-7. PubMed ID: 21927567
[TBL] [Abstract][Full Text] [Related]
16. Partial-Volume Effect Correction Improves Quantitative Analysis of 18F-Florbetaben β-Amyloid PET Scans.
Rullmann M; Dukart J; Hoffmann KT; Luthardt J; Tiepolt S; Patt M; Gertz HJ; Schroeter ML; Seibyl J; Schulz-Schaeffer WJ; Sabri O; Barthel H
J Nucl Med; 2016 Feb; 57(2):198-203. PubMed ID: 26541776
[TBL] [Abstract][Full Text] [Related]
17. Visualization of multiple organ amyloid involvement in systemic amyloidosis using
Ezawa N; Katoh N; Oguchi K; Yoshinaga T; Yazaki M; Sekijima Y
Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):452-461. PubMed ID: 28891012
[TBL] [Abstract][Full Text] [Related]
18.
Schindler TH; Sharma V; Imperiale A
JACC Cardiovasc Imaging; 2021 Jan; 14(1):256-258. PubMed ID: 32771579
[No Abstract] [Full Text] [Related]
19. Impact of partial volume effect correction on cerebral β-amyloid imaging in APP-Swe mice using [(18)F]-florbetaben PET.
Brendel M; Delker A; Rötzer C; Böning G; Carlsen J; Cyran C; Mille E; Gildehaus FJ; Cumming P; Baumann K; Steiner H; Haass C; Herms J; Bartenstein P; Rominger A
Neuroimage; 2014 Jan; 84():843-53. PubMed ID: 24055703
[TBL] [Abstract][Full Text] [Related]
20. Cardiac amyloidosis characterization by kinetic model fitting on [18F]florbetaben PET images.
Santarelli MF; Genovesi D; Scipioni M; Positano V; Favilli B; Giorgetti A; Vergaro G; Landini L; Emdin M; Marzullo P
J Nucl Cardiol; 2022 Aug; 29(4):1919-1932. PubMed ID: 33864226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
